Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze KNSA stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate KNSA investment potential.

What is KNSA stock price today?

Get real-time KNSA stock price, historical data, and price charts on Financhill. Track KNSA performance with our advanced analysis tools.

Is KNSA a good investment?

Evaluate KNSA investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy KNSA stock?

To buy KNSA stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of KNSA?

View detailed market capitalization data and company valuation metrics for KNSA on our comprehensive analysis page.

What is the P/E ratio of KNSA?

Use our fundamental analysis tools to view KNSA P/E ratio and compare valuation metrics with industry peers.

What are KNSA earnings?

View KNSA earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Kiniksa Pharmaceuticals International Plc Stock Predictions

Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.

Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets

Buy

KNSA
Kiniksa Pharmaceuticals International Plc

Last Price:

$42.13

Seasonality Move:

-5.23%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Kiniksa Pharmaceuticals International Plc Stock Forecast

Over the next 52 weeks, Kiniksa Pharmaceuticals International Plc has on average historically risen by 18.8% based on the past 7 years of stock performance.
Kiniksa Pharmaceuticals International Plc has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
Is Kiniksa Pharmaceuticals International Plc Stock Undervalued?

The current Kiniksa Pharmaceuticals International Plc [KNSA] share price is $42.44. The Score for KNSA is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
KNSA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Kiniksa Pharmaceuticals International Plc Stock Go Up Next Year?

Over the next 52 weeks, Kiniksa Pharmaceuticals International Plc has on average historically risen by 18.8% based on the past 7 years of stock performance.

Kiniksa Pharmaceuticals International Plc Stock Rating

Buy

Kiniksa Pharmaceuticals International Plc (KNSA) is a Buy

Is Kiniksa Pharmaceuticals International Plc overpriced?

Kiniksa Pharmaceuticals International Plc has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%

Kiniksa Pharmaceuticals International Plc Stock Price History

Is KNSA stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KNSA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United Kingdom

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

kiniksa.com

52-Week Data

52-Week High:

44.42

52-Week Low:

18.12

Prediction Charts

Market Cap:

3.3B

Price in USD:

42.44

Volume:

904K

Beta:

0.04

Technical Analysis

SMA50:

41.26

SMA100:

39.29

SMA200:

33.46

52-Wk Change:

120.93%

Stock Predictions

Is Kiniksa Pharmaceuticals International Plc stock public?

Yes, Kiniksa Pharmaceuticals International Plc is a publicly traded company.
What is the Kiniksa Pharmaceuticals International Plc stock quote today?

The Kiniksa Pharmaceuticals International Plc stock price is 42.44 USD today.
How to buy Kiniksa Pharmaceuticals International Plc stock online?

You can buy Kiniksa Pharmaceuticals International Plc shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-31	40.90	41.25	41.38	40.57
Jan-5	41.82	41.06	41.91	39.16
Jan-6	41.07	42.68	43.55	40.99
Jan-7	42.93	42.42	43.26	41.56
Jan-8	42.24	41.73	42.36	41.33
Jan-9	42.23	42.67	42.69	41.31
Jan-12	42.59	41.12	43.00	41.01
Jan-13	41.55	38.60	42.39	38.20
Jan-14	38.44	39.56	39.69	37.56
Jan-15	39.56	37.92	39.74	37.02
Jan-16	38.11	39.41	39.47	38.04
Jan-20	38.79	41.03	41.04	38.40
Jan-21	40.57	41.83	42.13	40.43
Jan-22	41.83	42.44	42.75	41.22

Kiniksa Pharmaceuticals International Plc Earnings

Kiniksa Pharmaceuticals International Plc Earnings Report: Per Share Kiniksa Pharmaceuticals International Plc Earnings Q1 Q2 Q3 and Q4 last year and next year.

Kiniksa Pharmaceuticals International Plc Forecast Revenue Growth

Kiniksa Pharmaceuticals International Plc Stock Analysis: Historical quarterly revenues per share for Kiniksa Pharmaceuticals International Plc and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.67 per share.

* Kiniksa Pharmaceuticals International Plc stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.